400 related articles for article (PubMed ID: 20193276)
21. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
[TBL] [Abstract][Full Text] [Related]
22. Propranolol for problematic head and neck hemangiomas: an analysis of 37 consecutive patients.
Lv MM; Fan XD; Su LX
Int J Pediatr Otorhinolaryngol; 2012 Apr; 76(4):574-8. PubMed ID: 22326207
[TBL] [Abstract][Full Text] [Related]
23. Hemangiomas of the nasal tip treated with propranolol.
Ben-Amitai D; Halachmi S; Zvulunov A; Raveh E; Kalish E; Lapidoth M
Dermatology; 2012; 225(4):371-5. PubMed ID: 23428617
[TBL] [Abstract][Full Text] [Related]
24. Intralesional corticosteroid therapy in hemangiomas: clinical outcome in 160 cases.
Chantharatanapiboon W
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S90-6. PubMed ID: 19253502
[TBL] [Abstract][Full Text] [Related]
25. [A prospective study of propranolol as first-line treatment for problematic infantile hemangioma in China].
Jin YB; Lin XX; Ye XX; Chen H; Ma G; Jiang CH; Da C; Chen XD; Hu XJ
Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 May; 27(3):170-3. PubMed ID: 21837993
[TBL] [Abstract][Full Text] [Related]
26. Clinical Outcomes of Infants With Periorbital Hemangiomas Treated With Oral Propranolol.
Xue L; Sun C; Xu DP; Liu ZM; Wang XK
J Oral Maxillofac Surg; 2016 Nov; 74(11):2193-2199. PubMed ID: 27235180
[TBL] [Abstract][Full Text] [Related]
27. Growth characteristics of infantile hemangiomas: implications for management.
Chang LC; Haggstrom AN; Drolet BA; Baselga E; Chamlin SL; Garzon MC; Horii KA; Lucky AW; Mancini AJ; Metry DW; Nopper AJ; Frieden IJ;
Pediatrics; 2008 Aug; 122(2):360-7. PubMed ID: 18676554
[TBL] [Abstract][Full Text] [Related]
28. Outpatient treatment of infantile hemangiomas with propranolol: a prospective study.
Betlloch-Mas I; Martínez-Miravete MT; Lucas-Costa A; Martin de Lara AI; Selva-Otalaurruchi J
Actas Dermosifiliogr; 2012 Nov; 103(9):806-15. PubMed ID: 22727954
[TBL] [Abstract][Full Text] [Related]
29. Propranolol reduces infantile hemangioma volume and vessel density.
Bingham MM; Saltzman B; Vo NJ; Perkins JA
Otolaryngol Head Neck Surg; 2012 Aug; 147(2):338-44. PubMed ID: 22691693
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
31. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
[TBL] [Abstract][Full Text] [Related]
32. [Oral propranolol in the management of periorbital proliferating phase infantile hemangioma].
Zhao ZF; Lü RR; Zhang J; Huo R; Xu GQ; Fu HB; Guo X; Wui JC; Lin LL
Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 May; 27(3):174-7. PubMed ID: 21837994
[TBL] [Abstract][Full Text] [Related]
33. Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma.
Denoyelle F; Leboulanger N; Enjolras O; Harris R; Roger G; Garabedian EN
Int J Pediatr Otorhinolaryngol; 2009 Aug; 73(8):1168-72. PubMed ID: 19481268
[TBL] [Abstract][Full Text] [Related]
34. Topical timolol maleate for superficial infantile hemangiomas: an observational study.
Xu DP; Cao RY; Tong S; Xue L; Sun NN; Wang XK
J Oral Maxillofac Surg; 2015 Jun; 73(6):1089-94. PubMed ID: 25843815
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and Safety of 2% Topical Propranolol Cream for the Treatment of Proliferating Infantile Strawberry Hemangiomas.
Wang Y; Zhang X; Yang Y; Zhang J; Yang Y; Lu Y
Indian J Pediatr; 2017 Jun; 84(6):425-429. PubMed ID: 28194699
[TBL] [Abstract][Full Text] [Related]
36. [Propanolol used in treatment of infantile hemangioma].
Guldbakke KK; Rørdam OM; Huldt-Nystrøm T; Hanssen HK; Høivik F
Tidsskr Nor Laegeforen; 2010 Sep; 130(18):1822-4. PubMed ID: 20882080
[TBL] [Abstract][Full Text] [Related]
37. Failure of intralesional propranolol in infantile hemangiomas.
Torres-Pradilla M; Baselga E
Pediatr Dermatol; 2014; 31(2):156-8. PubMed ID: 24000875
[TBL] [Abstract][Full Text] [Related]
38. Successful discontinuation of propranolol for infantile hemangiomas of the head and neck at 12 months of age.
Hong P; Tammareddi N; Walvekar R; Chiu ES; Poole JC; Kluka EA; Simon LM
Int J Pediatr Otorhinolaryngol; 2013 Jul; 77(7):1194-7. PubMed ID: 23706952
[TBL] [Abstract][Full Text] [Related]
39. Evolving treatments in the management of laryngotracheal hemangiomas: will propranolol supplant steroids and surgery?
Javia LR; Zur KB; Jacobs IN
Int J Pediatr Otorhinolaryngol; 2011 Nov; 75(11):1450-4. PubMed ID: 21880377
[TBL] [Abstract][Full Text] [Related]
40. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma.
Holland KE; Frieden IJ; Frommelt PC; Mancini AJ; Wyatt D; Drolet BA
Arch Dermatol; 2010 Jul; 146(7):775-8. PubMed ID: 20644039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
